Claudin 5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Claudin 5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Claudin-5 is a tight junction protein that forms the paracellular barrier of the [blood-brain barrier](/entities/blood-brain-barrier). It is essential for maintaining BBB integrity and preventing leakage of harmful substances into the brain [1].
Structure
Claudin-5 is a 218 amino acid protein with:
Four transmembrane domains
Two extracellular loops: The first extracellular loop determines charge selectivity
Cytoplasmic N- and C-termini: The C-terminus interacts with PDZ domain proteins including ZO-1, ZO-2, and ZO-3
Claudin-5 is essential for blood-brain barrier function:
Barrier Formation: Polymerizes into tight junction strands
Paracellular Transport: Controls passage of ions and small molecules
Selectivity: Provides size and charge selectivity
Tight Junction Assembly
Forms homotypic and heterotypic interactions with other claudins
Interacts with scaffolding proteins (ZO-1, ZO-2)
Links to actin cytoskeleton
Role in Neurodegeneration
Alzheimer's Disease
Claudin-5 expression is altered in AD brains
BBB breakdown correlates with cognitive decline
[Amyloid-beta](/proteins/amyloid-beta) can disrupt tight junctions [2]
Therapeutic targeting may improve drug delivery
Parkinson's Disease
Contributes to neuroinflammation by allowing peripheral immune cell entry
May affect [alpha-synuclein](/proteins/alpha-synuclein) clearance
Relevant for understanding treatment resistance
Stroke
Critical in acute BBB breakdown post-stroke
Target for stroke treatment strategies
Post-stroke repair involves claudin-5 restoration
Multiple Sclerosis
Claudin-5 is downregulated in active MS lesions
Contributes to immune cell infiltration
Potential therapeutic target
Therapeutic Implications
Drug Delivery
Targeting claudin-5 can enhance drug delivery to the brain
Transient opening of BBB for drug delivery
Focused ultrasound can modulate tight junctions
Biomarkers
Claudin-5 levels in blood may serve as BBB integrity markers
CSF/serum ratio indicates BBB damage
Gene Therapy
Potential for restoring BBB function
Viral vector delivery to endothelial cells
Key Publications
[Nitta et al., Claudin-5 and BBB integrity (2003)](https://doi.org/10.1083/jcb.200207055). Journal of Cell Biology.
[Wolburg et al., Tight junctions of the blood-brain barrier (2009)](https://doi.org/10.1016/j.neuroscience.2009.02.008). Neuroscience.
[Sweeney et al., Blood-brain barrier breakdown in Alzheimer's disease (2019)](https://doi.org/10.1038/s41582-019-0167-3). Nature Reviews Neurology.
Background
The study of Claudin 5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S, "Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice." Journal of Cell Biology (2003)](https://doi.org/10.1083/jcb.200207055)
[Wolburg H, Lippoldt A, Ebner B, "Tight junctions of the blood-brain barrier." Progress in Brain Research (2009)](https://doi.org/10.1016/j.neuroscience.2009.02.008)
[Sweeney MD, Sagare AP, Zlokovic BV, "Blood-brain barrier breakdown in Alzheimer's disease and other neurodegenerative disorders." Nature Reviews Neurology (2019)](https://doi.org/10.1038/s41582-019-0167-3)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate